Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma

Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma

Abstract Background Recurrence is common in glioblastoma multiforme (GBM) because of the infiltrative, residual cells in the tumor margin. Standard therapy for GBM consists of surgical resection followed by chemotherapy and radiotherapy, but the median survival of GBM patients remains poor (~ 1.5 ye...

Full description

Bibliographic Details
Main Authors: Hanwool Jeon, Joonho Byun, Hayeong Kang, Kyunggon Kim, Eunyeup Lee, Jeong Hoon Kim, Chang Ki Hong, Sang Woo Song, Young-Hoon Kim, Sangjoon Chong, Jae Hyun Kim, Soo Jeong Nam, Ji Eun Park, Seungjoo Lee
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Journal of Translational Medicine
Subjects:
Anti-angiogenic resistance
Prediction biomarker
Proteomics
Online Access:https://doi.org/10.1186/s12967-023-03936-8

Internet

https://doi.org/10.1186/s12967-023-03936-8

Similar Items